Header Logo

Connection

JOSEPH JANKOVIC to Receptors, Dopamine

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Receptors, Dopamine.
JOSEPH JANKOVIC
Connection Strength
0.293
Receptors, Dopamine
  1. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470.
    View in: PubMed
    Score: 0.130
  2. Choosing dopamine agonists in Parkinson's disease. Clin Neuropharmacol. 2001 Sep-Oct; 24(5):247-53.
    View in: PubMed
    Score: 0.045
  3. Switching from pergolide to pramipexole in patients with Parkinson's disease. J Neural Transm (Vienna). 2001; 108(1):63-70.
    View in: PubMed
    Score: 0.043
  4. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm (Vienna). 2000; 107(10):1165-73.
    View in: PubMed
    Score: 0.040
  5. Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5(1):83-4.
    View in: PubMed
    Score: 0.020
  6. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):63-73.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.